These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
179 related articles for article (PubMed ID: 36124532)
1. Identification of senescence-related molecular subtypes and key genes for prostate cancer. Feng DC; Zhu WZ; Shi X; Xiong Q; You J; Wei Q; Yang L Asian J Androl; 2023; 25(2):223-229. PubMed ID: 36124532 [TBL] [Abstract][Full Text] [Related]
2. Mitochondria Dysfunction-Mediated Molecular Subtypes and Gene Prognostic Index for Prostate Cancer Patients Undergoing Radical Prostatectomy or Radiotherapy. Feng D; Shi X; Zhang F; Xiong Q; Wei Q; Yang L Front Oncol; 2022; 12():858479. PubMed ID: 35463369 [TBL] [Abstract][Full Text] [Related]
3. Leucine zipper protein 2 serves as a prognostic biomarker for prostate cancer correlating with immune infiltration and epigenetic regulation. Feng D; Zhu W; Shi X; Wei W; Han P; Wei Q; Yang L Heliyon; 2022 Oct; 8(10):e10750. PubMed ID: 36217461 [TBL] [Abstract][Full Text] [Related]
4. Identification of circadian clock-related immunological prognostic index and molecular subtypes in prostate cancer. Che L; Li D; Wang J; Tuo Z; Yoo KH; Feng D; Ou Y; Wu R; Wei W Discov Oncol; 2024 Sep; 15(1):429. PubMed ID: 39259370 [TBL] [Abstract][Full Text] [Related]
5. Mitochondrial Aldehyde Dehydrogenase 2 Represents a Potential Biomarker of Biochemical Recurrence in Prostate Cancer Patients. Feng D; Zhu W; You J; Shi X; Han P; Wei W; Wei Q; Yang L Molecules; 2022 Sep; 27(18):. PubMed ID: 36144737 [TBL] [Abstract][Full Text] [Related]
6. An autophagy-related gene prognostic index predicting biochemical recurrence, metastasis, and drug resistance for prostate cancer. Zhu WZ; Feng DC; Xiong Q; Shi X; Zhang FC; Wei Q; Yang L Asian J Androl; 2023; 25(2):208-216. PubMed ID: 36412461 [TBL] [Abstract][Full Text] [Related]
7. A cellular senescence-related gene prognostic index for biochemical recurrence and drug resistance in patients with prostate cancer. Feng D; Shi X; You J; Xiong Q; Zhu W; Wei Q; Yang L Am J Cancer Res; 2022; 12(8):3811-3828. PubMed ID: 36119834 [TBL] [Abstract][Full Text] [Related]
8. A Ferroptosis-Related Gene Prognostic Index Associated With Biochemical Recurrence and Radiation Resistance for Patients With Prostate Cancer Undergoing Radical Radiotherapy. Feng D; Shi X; Xiong Q; Zhang F; Li D; Wei W; Yang L Front Cell Dev Biol; 2022; 10():803766. PubMed ID: 35223835 [No Abstract] [Full Text] [Related]
9. Establishment of cancer-associated fibroblasts-related subtypes and prognostic index for prostate cancer through single-cell and bulk RNA transcriptome. Qian Y; Feng D; Wang J; Wei W; Wei Q; Han P; Yang L Sci Rep; 2023 Jun; 13(1):9016. PubMed ID: 37270661 [TBL] [Abstract][Full Text] [Related]
10. Energy Metabolism-Related Gene Prognostic Index Predicts Biochemical Recurrence for Patients With Prostate Cancer Undergoing Radical Prostatectomy. Feng D; Shi X; Zhang F; Xiong Q; Wei Q; Yang L Front Immunol; 2022; 13():839362. PubMed ID: 35280985 [TBL] [Abstract][Full Text] [Related]
11. Senescence-associated secretory phenotype constructed detrimental and beneficial subtypes and prognostic index for prostate cancer patients undergoing radical prostatectomy. Feng D; Wang J; Li D; Wu R; Wei W; Zhang C Discov Oncol; 2023 Aug; 14(1):155. PubMed ID: 37624511 [TBL] [Abstract][Full Text] [Related]
12. A Novel Set of Immune-associated Gene Signature predicts Biochemical Recurrence in Localized Prostate Cancer Patients after Radical Prostatectomy. Luan JC; Zhang QJ; Zhao K; Zhou X; Yao LY; Zhang TT; Zeng TY; Xia JD; Song NH J Cancer; 2021; 12(12):3715-3725. PubMed ID: 33995646 [No Abstract] [Full Text] [Related]
13. A gene prognostic index from cellular senescence predicting metastasis and radioresistance for prostate cancer. Feng D; Li D; Shi X; Xiong Q; Zhang F; Wei Q; Yang L J Transl Med; 2022 Jun; 20(1):252. PubMed ID: 35658892 [TBL] [Abstract][Full Text] [Related]
14. MicroRNA-regulated transcriptome analysis identifies four major subtypes with prognostic and therapeutic implications in prostate cancer. Lin BB; Lei HQ; Xiong HY; Fu X; Shi F; Yang XW; Yang YF; Liao GL; Feng YP; Jiang DG; Pang J Comput Struct Biotechnol J; 2021; 19():4941-4953. PubMed ID: 34527198 [TBL] [Abstract][Full Text] [Related]
15. Tumor infiltrating M2 macrophages could predict biochemical recurrence of localized prostate cancer after radical prostatectomy. Zhang Q; Xia J; Wang Y; Zhang J; Ji C; Cong R; Wang Y; Song N Exp Cell Res; 2019 Nov; 384(1):111588. PubMed ID: 31473209 [TBL] [Abstract][Full Text] [Related]
16. DNA methylation screening of primary prostate tumors identifies SRD5A2 and CYP11A1 as candidate markers for assessing risk of biochemical recurrence. Horning AM; Awe JA; Wang CM; Liu J; Lai Z; Wang VY; Jadhav RR; Louie AD; Lin CL; Kroczak T; Chen Y; Jin VX; Abboud-Werner SL; Leach RJ; Hernandez J; Thompson IM; Saranchuk J; Drachenberg D; Chen CL; Mai S; Huang TH Prostate; 2015 Nov; 75(15):1790-801. PubMed ID: 26332453 [TBL] [Abstract][Full Text] [Related]
17. Identification a novel set of 6 differential expressed genes in prostate cancer that can potentially predict biochemical recurrence after curative surgery. Li F; Ji JP; Xu Y; Liu RL Clin Transl Oncol; 2019 Aug; 21(8):1067-1075. PubMed ID: 30637711 [TBL] [Abstract][Full Text] [Related]
18. Tertiary Gleason pattern in radical prostatectomy specimens is associated with worse outcomes than the next higher Gleason score group in localized prostate cancer. Özsoy M; D'Andrea D; Moschini M; Foerster B; Abufaraj M; Mathieu R; Briganti A; Karakiewicz PI; Roupret M; Seitz C; Czech AK; Susani M; Shariat SF Urol Oncol; 2018 Apr; 36(4):158.e1-158.e6. PubMed ID: 29288003 [TBL] [Abstract][Full Text] [Related]
19. Integrative RNA profiling of TBEV-infected neurons and astrocytes reveals potential pathogenic effectors. Selinger M; Věchtová P; Tykalová H; Ošlejšková P; Rumlová M; Štěrba J; Grubhoffer L Comput Struct Biotechnol J; 2022; 20():2759-2777. PubMed ID: 35685361 [TBL] [Abstract][Full Text] [Related]
20. Prediction of Biochemical Recurrence Following Radiotherapy among Patients with Persistent PSA after Radical Prostatectomy: A Single-Center Experience. Xiang C; Liu X; Chen S; Wang P Urol Int; 2018; 101(1):47-55. PubMed ID: 29627830 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]